# Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.

> **NCT07536841** · — · NOT_YET_RECRUITING · sponsor: **Military Medical Clinical Center of the Southern Region, Ukraine** · enrollment: 82 (estimated)

## Conditions studied

- Autoimmune Pancreatitis
- IgG4-Related Diseases
- Pancreatic Cancer
- Chronic Pancreatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07536841
- **Lead sponsor:** Military Medical Clinical Center of the Southern Region, Ukraine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07536841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07536841, "Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07536841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*